-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $4.5

Benzinga·12/15/2025 18:25:43
Listen to the news
Wells Fargo analyst Brandon Couillard maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $4 to $4.5.